COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
Eliminated vs. Eradicated: Erasing disease from history — Atlantic Health Partners
Host genetics and infectious disease: new tools, insights and translational opportunities | Nature Reviews Genetics
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
Enhancing genetic disease control by selecting for lower host infectivity and susceptibility | Heredity
Vaccine and vaccination as a part of human life: In view of COVID‐19 - K.B. - 2022 - Biotechnology Journal - Wiley Online Library
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
The role of vaccines in combatting antimicrobial resistance | Nature Reviews Microbiology
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease - ScienceDirect
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology
MMWR COVID-19 Reports | MMWR
Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection - ScienceDirect
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances
Peptides for Vaccine Development | ACS Applied Bio Materials
Vaccines have helped eradicate major diseases in the US | World Economic Forum
Designing spatial and temporal control of vaccine responses | Nature Reviews Materials
Disease Eradication: What Does It Take to Wipe out a Disease?
Efficient Bacterial Genome Engineering throughout the Central Dogma Using the Dual-Selection Marker tetAOPT | ACS Synthetic Biology
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
Vaccines | Free Full-Text | Progress and Prospects on Vaccine Development against SARS-CoV-2
